XLV241220C145500
- 0.09
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Pfizer Gains FDA Approval for Colorectal-Cancer Treatment
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.
① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.
Wall Street Suffers Worst Week in Over a Month After Fed Delivers a Reality Check
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Novo Nordisk Raises Expectations for Eli Lilly After CagriSema Slipup
Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?
Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?
The Health Care Select Sector SPDR Fund To Go Ex-Dividend On December 23rd, 2024 With 0.62165 USD Dividend Per Share
Friday Market Rebounds Some of Weeks Loss | Wall Street Today
Pfizer Gets FDA Accelerated Approval for Braftovi
FDA Grants Accelerated Approval To Encorafenib With Cetuximab And MFOLFOX6 For Metastatic Colorectal Cancer With A BRAF V600E Mutation
Government Shutdown Threat: Stocks Wobble, Holiday Travel And Paychecks Could Face Delays: What You Need To Know
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
J.P. Morgan's Top Healthcare Stocks for 2025
Merck Downgraded by BMO Over Keytruda Concerns
RxSight Cut to Hold at Stifel on Competition Concerns
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead
Sector Update: Health Care Stocks Mixed Premarket Friday